Not for emergencies. Call 911 if experiencing medical emergency.

Education

Peptide Guide

Explore clinician-guided education on semaglutide, tirzepatide, sermorelin, tesamorelin, NAD+, glutathione, GHK-Cu, and PT-141. Each page explains what the treatment is, where evidence is stronger or weaker, what risks matter, and what to review with a licensed clinician.

Weight and Metabolic

Semaglutide

Educational guide to clinician-supervised semaglutide pathways for appetite regulation, titration, side effects, and refill continuity.

Tirzepatide

Educational guide to tirzepatide candidacy, semaglutide comparison points, tolerability, and clinician review.

Growth Hormone Axis and Body Composition

Tesamorelin

Guide to tesamorelin with narrower approved-indication context, body-composition framing, and monitoring questions.

Sermorelin

Conservative overview of sermorelin discussions for recovery, sleep quality, and body-composition goals.

Energy and Recovery

NAD+

Evidence-limited overview of NAD+ route options, expectations, and safety questions for recovery discussions.

Glutathione

Route-focused guide to glutathione with practical tradeoffs, evidence limits, and clinician-guided questions.

Skin, Hair, and Sexual Wellness

GHK-Cu

Topical GHK-Cu guide for cautious skin and hair support discussions where evidence remains limited and early-stage.

PT-141

Indication-aware PT-141 guide covering mechanism, timing, and clinician-guided sexual-wellness review.

This guide is educational only. Peptide pathways require licensed clinician review, and compounded medications discussed through New Blue are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.

Start Your Visit